These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35513366)
1. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway. Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance. Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Huang Z; Zhang M; Li J; Lou C Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852. Ouyang H; Zhang L; Xie Z; Ma S Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506 [TBL] [Abstract][Full Text] [Related]
5. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis. Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8. Ruan Z; Deng H; Liang M; Xu Z; Lai M; Ren H; Deng X; Su X Cancer Cell Int; 2020; 20():511. PubMed ID: 33093810 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15. Li H; Zhang GY; Pan CH; Zhang XY; Su XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134 [TBL] [Abstract][Full Text] [Related]
10. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer. Li C; Wu R; Xing Y Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MAFG-AS1 is involved in human cancer progression. Li P; Ma X; Gu X Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis. Sun X; Cai Y; Hu X; Mo M; Zhao C; He W; Li Y Transl Cancer Res; 2020 Nov; 9(11):7214-7226. PubMed ID: 35117325 [TBL] [Abstract][Full Text] [Related]
13. Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer. Chen T; Huang B; Pan Y Front Cell Dev Biol; 2021; 9():688603. PubMed ID: 34386494 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis. Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437 [TBL] [Abstract][Full Text] [Related]
15. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA. Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778 [TBL] [Abstract][Full Text] [Related]
16. Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis. Lin G; Liu H; Lin J; Liu X; Xu L Front Oncol; 2023; 13():1286610. PubMed ID: 38130989 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation. Fu Y; Wen J; Li X; Gong M; Guo Z; Wang G Crit Rev Eukaryot Gene Expr; 2021; 31(5):27-32. PubMed ID: 34591387 [TBL] [Abstract][Full Text] [Related]
18. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15. Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 invitro. Gao Z; Zheng G; Gong X; Hu H; Shao L; Pang Y; Wang Y; Qi A Biochem Biophys Res Commun; 2022 Aug; 616():95-103. PubMed ID: 35653827 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4. Cui S; Yang X; Zhang L; Zhao Y; Yan W Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]